François R. Martelet

About

François R. Martelet is a physician-executive in biopharma and oncology with more than 30 years in pharmaceutical and biotech leadership. He has served as CEO of Scandion Oncology and previously led NetScientific, while also chairing/leading multiple oncology and specialty-pharma businesses including Glycotest, Vivesto, TopoTarget, and AVAX Technologies. He currently appears publicly as a business advisor to Cleara Biotech and a board member of Novigenix.

Areas of interest